Connect with us

Buzz

‘Homeopathy effective in management of long COVID’ shows patient data at Dr. Kalyan Banerjee’s Clinic

NEW DELHI, April 8, 2022 /PRNewswire/ — Homeopathic treatment has proven effective in the management of several health disorders seen in patients for many months after recovering from Covid-19 infection (‘Long Covid’), an analysis of patient data from the last two years at  Dr. Kalyan Banerjee’s Clinic in Delhi has shown.
“We are currently treating hundreds of patients suffering from health conditions triggered by Covid such as stroke, serious lung damage, cardiac damage, rhythm disorders, kidney disease, post-traumatic stress, anxiety, mood disorders and Guillain-barre Syndrome. Anecdotal evidence of hundreds of patients seems to indicate that Homeopathy appears to benefit in managing these disorders,” said Dr. Kalyan Banerjee, Padma Shri recipient and the founder of Dr. Kalyan Banerjee’s Clinic, one of Delhi-NCR’s most renowned homeopathy clinic. “Patients suffering from long COVID symptoms should definitely consider homeopathic treatment either as exclusive or as an add-on to allopathic medicine for optimum outcomes.” 
He said that homeopathy was also found to be effective in the prevention of Covid-19 as well as the management of patients who caught the virus. Dr. Kalyan Banerjee’s Clinic developed a homeopathy prophylaxis protocol for prevention of Covid-19 as soon as the pandemic began. It dispensed 2 lakh courses of this protocol in India alone, helping protect people from the dreaded infection. It is today counted among the world’s most popular homeopathic prophylaxis protocols and the only one to have been validated in an evidence-based manner.
Dr. Kalyan Banerjee said, “The prophylaxis protocol was developed by us in early days of the pandemic. A huge dataset of 15,000 of our patients from 18 countries was analysed and a protective effect of the protocol was found against Covid-19. Seeing its effectiveness, the protocol was requested by thousands of patients and doctors in several hospitals around the world.”
Doctors at Dr. Kalyan Banerjee’s Clinic were involved in the management of severe COVID-19 cases, seeing more than 100 Covid patients a day in the peak of the pandemic, including those suffering from multiple organ dysfunction syndrome. More than 50 Covid patients admitted in ICU were managed with homeopathic medicines as an add-on during the Delta wave. “Over 30% of these intensive care patients recovered,” said Dr. Kalyan Banerjee.
Findings from the ongoing retrospective observational studies conducted by Dr Banerjee’s Clinic have also shown the positive impact of homeopathy interventions on a significant percentage of patients of chronic kidney disease / kidney failure and hypothyroidism. For the purposes of these studies, a catchment period was defined and data of patients with these conditions coming to Dr Kalyan Banerjee’s clinic during that period was extracted.
Dr. Kushal Banerjee, a second-generation homeopath at Dr. Kalyan Banerjee’s Clinic said, “The hypothyroidism study analysed the records of 3,500 patients at our Clinic. It was found that by the time of third visit to the clinic, more that 50% of patients of hypothyroidism demonstrated an improvement in their serum thyroid stimulating hormone readings. The chronic kidney disease study analysed the records of 520 patients. It found that by the third visit to the clinic, 58.3% patients demonstrated an improvement in their serum urea readings while 74.2% patients showed improvement in creatinine levels after first and second visits to the Clinic.”
He added, “The early observations are very interesting. In the hypothyroidism study, the data seems to indicate that specific homeopathic medicines given to patients were able to improve the functioning of the thyroid gland, thereby bringing down the thyroid stimulating hormone readings. This has the potential of reducing – or entirely stopping – the dosage of thyroid hormone replacement in patients. More than half of patients of hypothyroidism benefitting from homeopathic medicines is a very significant number, considering that 11% of Indian population suffers from hypothyroidism.”
He further added, “In the chronic kidney disease study, two of the most clinically important readings in patients – serum urea and creatinine – showed vast improvement. No currently available treatment is able to affect a reduction in these parameters. This study may turn out to be of immense benefit to patients. Since these readings are a part of the decision-making process of whether to start dialysis or not, homeopathic treatment may help patients avoid the start of dialysis.”
Doctors at Dr. Kalyan Banerjee’s Clinic see an average of 40 cases of hypothyroidism and 25 cases of chronic kidney disease every day. They practice an evidence-based approach and have arrived at specific medicine and potency combinations for specific diseases using the clinical experience of millions of prescriptions over four decades.
About Dr. Kalyan Banerjee
Dr. Kalyan Banerjee has been associated with several government agencies such as the Central Council for Research in Homoeopathy, Ministry of Health and Family Welfare, formerly a member of their Governing Council, and the Central Council for Research in Homoeopathy (CCRH) of the Ministry of AYUSH, holding a seat in the Homeopathic Pharmacopoeia Committee and the Standing Finance Committee. The Government of India awarded him the fourth highest civilian honour of the Padma Shri in 2009, for his contributions to Medicine.
About Dr. Kushal Banerjee
Dr. Kushal Banerjee received his undergraduate degree from Indraprastha University and completed his MD in Homeopathy from Ludhiana. He went on to read for a Master of Science in Evidence Based Medicine at the University of Oxford. The best available information indicates that he is the only homeopath to have ever been admitted to read at Oxford. He is a member of the British Register of Complementary Medicine, England. He has lead-authored research on homeopathy with collaborators from the University of Oxford and Imperial College, London. This is the only example of such a collaboration between these two institutions on homeopathy. He is the only homeopath to have ever been selected to present a paper at ‘Evidence Live’ – a prestigious convention organised by the Centre for Evidence Based Medicine, University of Oxford and the British Medical Journal. 
About Dr. Kalyan Banerjee’s Clinic 
The Clinic was founded in 1977 and now treats several hundred patients every day. The rates of cure achieved here, far surpass conventional homeopathy and the Clinic has built a reputation for effective, evidence-based practices with patients and illnesses that are complicated, difficult and in many cases, life threatening. The experienced and well-trained team of doctors at the Clinic is led by Dr. Kalyan Banerjee, an accomplished physician with four decades of practice. The Clinic has been responsible for several million charitable prescriptions over four decades. In addition, facilitation of research, publication and protocol development, are amongst their various philanthropic activities. The clinic also has branches in Noida and Gurgaon now making it very convenient for patients in surrounding areas of Delhi and the National Capital Region for picking up medicines. 
The distinctive USP of the clinic is that all patients are provided prescriptions and names of medicines. While these are available at homeopathic pharmacies, patients prefer to take it from Dr. Kalyan Banerjee’s Clinic and centres because of their faith in the high quality of medicines used. A few proprietary homeopathic preparations and medicines are exclusively only available at the Clinic and centres. 
Website:  https://www.drkbanerjee.com

Related Topics:
Continue Reading
Advertisement
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Buzz

Apollo Athenaa Launches ‘Holding Hope’, India’s First Dedicated Handbook for Cancer Caregivers, during National Cancer Survivors Month

Authored by Dr. Jyoti Wadhwa, Principal Lead – Medical and Precision Oncology, Apollo Athenaa, the handbook aims to empower caregivers with practical guidance, emotional support, and clinical insights throughout the cancer journeyNEW DELHI, June 16, 2026 /PRNewswire/ — Marking Cancer Survivors Month and reinforcing the importance of holistic cancer care, Apollo Athenaa, Asia’s first comprehensive cancer centre dedicated exclusively to women, marked a significant step in India’s oncology support landscape with the launch of Holding Hope: A Handbook for Cancer Caregivers—India’s first dedicated resource designed exclusively to support individuals caring for loved ones with cancer.

While cancer survivorship is often celebrated through the resilience and recovery of patients, the journey is rarely undertaken alone. Behind every survivor is a network of family members and caregivers who provide emotional, physical, logistical, and financial support throughout diagnosis, treatment, recovery, and beyond. Data indicates that 95 per cent of cancer patients in India have at least one primary caregiver; 57 per cent are supported by three to four caregivers, and 23 per cent have five to seven individuals involved in their care1. Yet despite their critical role, caregivers often navigate this demanding responsibility without access to structured guidance or dedicated support.Recognising this unmet need, Holding Hope: A Handbook for Cancer Caregivers has been authored by Dr. Jyoti Wadhwa, Principal Lead – Medical and Precision Oncology, Apollo Athenaa, along with Dr. Hussain Shaik, Associate Consultant – Medical Oncology, Apollo Athenaa. Drawing on years of clinical experience and patient interactions, the handbook serves as a practical companion for caregivers, offering actionable guidance on managing treatment journeys, navigating difficult conversations, supporting emotional well-being, understanding medical decisions, and prioritising self-care.Speaking on the occasion, Dr. Jyoti Wadhwa, Principal Lead, Medical and Precision Oncology, Apollo Athenaa said, “When we celebrate cancer survivors, it is equally important to acknowledge the caregivers who stand beside them through every treatment cycle, every setback, and every milestone. With over 15 lakh new cancer cases reported in India in 20242, the number of families navigating the complexities of cancer care continues to grow. Caregivers are often the silent pillars of strength in a patient’s journey, yet many feel unprepared for the emotional and practical challenges that come with the role. Through Holding Hope, we wanted to create a trusted resource that equips caregivers with knowledge, confidence, and reassurance at every stage of the cancer journey.”Sharing his experience as a caregiver, Mr. Sudesh, who has supported his wife through her cancer journey said, “When a loved one is diagnosed with cancer, caregivers often find themselves navigating uncertainty, difficult decisions, and emotional challenges with little guidance. The launch of Holding Hope is a welcome initiative. Its practical advice on managing treatment, understanding medical decisions, supporting emotional well-being, and prioritising self-care will help many caregivers like me feel more informed, prepared, and supported.”Highlighting the importance of equipping caregivers with the right knowledge and support, Dr. Hussain Shaik, Associate Consultant, Medical Oncology, Apollo Athenaa added, “Caregivers play a vital role in the cancer journey, often serving as the bridge between patients and healthcare teams. However, many find themselves navigating complex medical decisions, treatment-related challenges, and emotional stress with little formal guidance.” This handbook combines evidence-based medical information with practical caregiving strategies and real-life experiences to help caregivers better understand their role and foster stronger communication with patients and clinicians. Importantly, it also addresses an often-overlooked aspect of caregiving, the need for caregivers to prioritise their own physical and emotional well-being while supporting their loved ones.The launch of Holding Hope reflects Apollo Athenaa’s broader vision of advancing patient-centred and family-centred cancer care. By placing caregivers at the heart of the oncology continuum, the initiative seeks to strengthen support systems that contribute meaningfully to patient outcomes, quality of life, and long-term survivorship.As conversations around cancer care continue to evolve, Apollo Athenaa hopes that Holding Hope will encourage greater recognition of caregivers and foster a more compassionate, informed, and inclusive approach to cancer survivorship in India.1 Profile of cancer caregivers among adult Indian rural cancer patients: A prospective survey. | Journal of Clinical Oncology 2 https://sansad.in/getFile/loksabhaquestions/annex/185/AU3233_xEZ9oE.pdf?source=pqalsAbout Apollo AthenaaApollo Athenaa, a unit of Apollo Hospitals Enterprise Ltd, is Asia’s first dedicated cancer centre for women, rooted in empathy and powered by science. It is not just a facility—it’s a mission. Apollo Athenaa is envisioned as a safe, specialised space exclusively for women, combining cutting-edge oncology expertise with compassion, dignity, and privacy. Women are the cornerstones of families and communities, and their health directly impacts the strength of the nation. Recognising the need for timely, specialised, and compassionate care, Apollo has taken a pioneering step forward. Apollo Athenaa provides comprehensive women-focused cancer care, from preventive screenings and advanced diagnostics to surgical oncology, breast oncoplasty, fertility preservation, and reconstructive care. Supported by multidisciplinary expertise and precision oncology, the centre also offers nutrition, physiotherapy, onco-psychology, and palliative care, ensuring a continuum of services that place women’s health, dignity, and well-being at the forefront. Log on to: https://www.apollohospitals.com/hospitals/apollo-athenaa-womens-cancer-centre 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/apollo-athenaa-launches-holding-hope-indias-first-dedicated-handbook-for-cancer-caregivers-during-national-cancer-survivors-month-302801636.html

Continue Reading

Buzz

Affle Announces Strategic Acquisition of AdColony Technology Assets and Trademark from DT

Acquisition Strengthens Affle 3i Consumer Platform Tech Stack and Reinforces Commitment to Accelerated Growth with Ongoing Commercial Partnership with DTSAN FRANCISCO and GURUGRAM, India, June 16, 2026 /PRNewswire/ — Affle, a global technology company that delivers premium consumer conversions for advertisers with its verticalized AI-powered Consumer Platform, announced that Affle MEA FZ LLC has entered into a definitive asset purchase agreement with DT (NASDAQ: APPS), formerly Digital Turbine, to acquire select strategic AdColony assets including the AdColony SDK for Android and iOS devices, tech platform, existing integration with in-app publishers and mediation platforms, the brand name, domain and the goodwill exclusively related to the assets.

The acquisition aligns with Affle’s 10X growth strategy to augment its Consumer Platform technology stack with broader SDK reach, spanning a wide and diverse range of mobile publisher connections globally. Affle’s deep verticalization strategy and expanded IP portfolio ensure enhanced human-vs-non-human data distillation to drive premium consumer conversions through its differentiated CPCU (Cost Per Converted User) business model.”We are excited to announce this strategic acquisition of assets as part of our 10X growth plan,” said Anuj Khanna Sohum, Chairperson, MD & CEO of Affle. “The integration of AdColony is a significant step towards driving global scale for Affle’s advertisers with premium conversions powered by deeper audience intelligence across all our industry verticals. With our integrated stack, we will unlock greater ROI for our advertisers and publishers alike, and thus drive long-term value for our stakeholders.”The transaction enables DT to further focus investment and resources on its core media and distribution platforms and differentiated data and intelligence assets.”We made the strategic decision following our Fyber and AdColony acquisitions to consolidate around a single exchange platform, which became the foundation for what is now DTX,” said Bill Stone, CEO of DT. “That decision allowed us to simplify our technology stack, focus our investment, and build a stronger long-term platform. Affle is a natural partner for these AdColony assets, and this transaction creates an opportunity to deepen our commercial relationship, leveraging our respective supply, demand and technology strengths to deliver greater value for advertisers, publishers and partners.””This acquisition reinforces Affle’s commitment to continuously scaling globally and delivering personalized recommendations across the connected consumer journeys,” said Sameer Sondhi, CEO of North America and Chief Strategic Investments Officer at Affle. “AdColony brings a long-standing and trusted reputation with publishers globally that complements Affle’s broader strategy. The acquisition further strengthens Affle’s ability to drive deeper engagement with both existing and new advertisers worldwide. Enhanced reach, combined with richer audience intelligence for premium consumer conversions, will enable truly differentiated impact.”Through this acquisition and its ongoing commercial partnership with DT, Affle aims to deliver enhanced value for advertisers, publishers and stakeholders globally.About Affle Inc.Affle Inc. is a global technology company enabling verticalized AI-led consumer conversions for advertisers globally, powered by the differentiated CPCU business model across Mobile, CTV and other agentic/autonomous intelligent connected devices (AICDs). Affle 3i Consumer Platform enables advertisers to optimize targeting, personalize user engagement and maximize ROI by combining proprietary data, deep audience intelligence and advanced agentic AI capabilities. With innovative technology integrations, Affle maximizes user engagement at every stage of the consumer journey across connected devices with algorithms that go beyond automation and efficiency to deliver next-gen experiences through deep human-vs-non-human data distillation.Affle Inc. is a step-down US subsidiary of Affle 3i Limited, which is listed on the NSE: AFFLE and BSE: 542752.For more information, visit – www.affle.com   

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/affle-announces-strategic-acquisition-of-adcolony-technology-assets-and-trademark-from-dt-302801554.html

Continue Reading

Buzz

U.S. News Unveils 2026-2027 Best Global Universities Rankings

Universities in more than 100 countries are evaluated in the newest edition. WASHINGTON, June 16, 2026 /PRNewswire/ — U.S. News & World Report, the global authority in education rankings and consumer advice, today published the 2026-2027 Best Global Universities rankings, which evaluate more than 2,250 schools on academic research and reputation.

The latest edition includes universities from more than 100 countries. The following countries have the most schools in the overall rankings:China: 409United States: 275India: 123United Kingdom: 93Japan: 86″For students seeking universities with strong academic excellence and global recognition, the Best Global Universities rankings offer an essential comparative resource,” said LaMont Jones, Ed.D., managing editor for Education at U.S. News. “Our methodology focuses on a school’s research mission and scholarly impact, helping students identify institutions that are truly at the forefront of global knowledge creation.”Of the 51 subject rankings, four will have more schools ranked this year, including: water resources; chemical engineering; energy and fuels; and clinical medicine.Powered by data and metrics from the Web of Science Core Collection and InCites Benchmarking & Analytics provided by Clarivate, a leading global provider of transformative intelligence, the Best Global Universities methodology weighs factors that measure a university’s global and regional research reputation and academic research performance.For the overall ranking, this includes bibliometric indicators such as publications, citations and international collaboration. Each of the 51 subject rankings has its own weighting based on academic research performance in that specific area.2026-2027 U.S. News & World Report Best Global Universities*See the full rankings here.Overall Best Global Universities – Top 10Harvard UniversityMassachusetts Institute of Technology (MIT)Stanford UniversityUniversity of OxfordUniversity of CambridgeTsinghua UniversityUniversity of California BerkeleyYale UniversityUniversity College LondonColumbia UniversityAfrica – Top 3University of Cape Town (South Africa)Cairo University (Egypt)University of Witwatersrand (South Africa)Asia – Top 3Tsinghua University (China)National University of Singapore (Singapore)Peking University (China)Australia/New Zealand – Top 3University of Melbourne (Australia)University of Sydney (Australia)University of New South Wales Sydney (Australia)Europe – Top 3University of Oxford (United Kingdom)University of Cambridge (United Kingdom)University College London (United Kingdom)Latin America – Top 3Universidade de Sao Paulo (Brazil)Pontificia Universidad Catolica de Chile (Chile)University of Buenos Aires (Argentina)The Best Global Universities rankings serve the broader U.S. News mission of providing trusted information and rankings – such as Best High Schools, Best Colleges and Best Online Programs – to empower all students in making informed choices about their education.For more information on the Best Global Universities, visit X, TikTok, Facebook and Instagram using #BestGlobal.About U.S. News & World ReportU.S. News & World Report is the global leader for journalism that empowers consumers, citizens, business leaders and policy officials to make confident decisions in all aspects of their lives and communities. A multifaceted media company, U.S. News provides unbiased rankings, independent reporting and analysis, and consumer advice to millions of people on USNews.com each month. A pillar in Washington for more than 90 years, U.S. News is the trusted home for in-depth and exclusive insights on education, health, politics, the economy, insurance, personal finance, travel, automobiles, real estate, careers and consumer products and services.About ClarivateClarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/us-news-unveils-2026-2027-best-global-universities-rankings-302800774.html

Continue Reading

Trending